ENCyberKnife treatment in Germany is robotic radiosurgery: precisely aimed radiation delivered by a robot. Despite the name there is no knife, and the patient simply lies still during the session. Most readers want to know whether surgery or a long course of daily radiotherapy can be avoided; that depends on the size, number and position of the lesions, not on preference.
Below: how the method works, which tumours it is used for in Germany, how it differs from the Gamma Knife and proton therapy, and where its limits lie. Whether it suits a particular patient is for a tumour board to decide from the imaging and histology (tissue analysis). Overview: cancer treatment in Germany.
How robotic radiosurgery works
A compact linear accelerator, the machine that produces the radiation, sits on a robotic arm and aims thin beams at the tumour from many angles. Each beam alone is weak, but where they overlap, enough dose builds up to damage tumour cells’ DNA, while surrounding tissue receives little.
The real difference from conventional radiotherapy is tracking: during the session the system takes images, sees where the tumour is at that moment and follows it as the patient breathes. So no rigid frame is fixed to the skull; the patient lies in a custom mask or on a body-shaped vacuum mattress.
The course is short because the dose is concentrated in a small target: one to five sessions instead of around thirty daily ones. That is not rushed radiotherapy but a different dose distribution, high in the lesion and low around it. More from the German Cancer Information Service on stereotactic radiosurgery (Krebsinformationsdienst, in German).
Which tumours it is used for
It is most often used for small, clearly bounded lesions: brain metastases, small lung tumours in patients who cannot tolerate surgery, and lesions in the spine or liver. For pancreatic tumours the German guideline advises it mainly within clinical trials; in prostate cancer it is used in certain protocols. See also brain tumour treatment in Germany.
It is discussed instead of surgery when radiation can reach the lesion but an operation is high-risk because of its position or the patient’s general condition. It may also be added to other treatment: local control of one active lesion while systemic, whole-body therapy holds the rest.
The limits, said plainly: large tumours, many scattered lesions and diffuse involvement of an organ are not what it is for. Radiation acts only where the beams are aimed, so where disease has spread, no form of radiation replaces systemic treatment (see cancer treatment in Germany).
How it differs from the Gamma Knife, protons and standard radiotherapy
In short: wider reach than the Gamma Knife, different radiation from protons, and tracking over fewer sessions than standard radiotherapy. The Gamma Knife works only in the head and upper spine, usually with a fixation frame, while the robotic system is mobile and used throughout the body. Proton therapy differs not in aiming accuracy but in its particles, whose dose stops just beyond the tumour; it is chosen on other grounds, often in children and near critical structures.
So «which machine is better» is the wrong question: the choice is made for a specific lesion, not for a brand of equipment. In Germany that decision is taken by a tumour board with a radiation oncologist at the table.
Preparation and the session itself
Preparation takes longer than the treatment: a planning CT, often an MRI or PET-CT too, image fusion and a plan calculated by a medical physicist with the doctor. For lesions in the lung, liver or prostate, small marker seeds are sometimes placed beforehand so the system has something to hold on to.
A session lasts from half an hour to about an hour. There is no anaesthetic and no incision, and the radiation is not felt; the patient lies there while the robotic arm moves around. With several sessions, there is usually a day or two between them.
Afterwards there may be tiredness, then reactions that depend on the region treated. The effect is not immediate: follow-up imaging is done weeks and months later, and a lesion still visible on the first scan does not mean the treatment failed.
What a German clinic needs to give a real answer
Without imaging there is no conversation: recent MRI or CT as files rather than printouts, the histology report, summaries of earlier treatment and details of any previous irradiation of that region. That last point matters enormously: irradiated tissue is more sensitive, and re-irradiation is limited by the dose already received. A second opinion from a German doctor reviews everything independently.
The clinic then sends an opinion on whether the method is suitable, a plan with the number of sessions and a written estimate in the patient’s name; payment goes directly to the clinic. What makes up the bill: cost of radiotherapy in Germany.
Frequently asked questions
How many CyberKnife sessions are needed?
Usually one to five. A small brain metastasis is often treated in a single session, which is radiosurgery in the narrow sense; larger lesions and those near sensitive structures need several sessions, sometimes more than five. The exact number comes from the treatment plan.
What side effects can follow CyberKnife treatment?
They depend on the region treated; tiredness can also occur. After brain treatment, swelling sometimes develops and usually settles by itself; near the chest wall, pain or even a rib fracture can occur months later; prostate treatment can cause urinary problems and rectal irritation.
Can CyberKnife be used if the area has already been irradiated?
Sometimes, but only after the earlier treatment has been reviewed. Repeat irradiation carries a higher risk of side effects, and the cumulative dose to previously irradiated healthy tissue must stay acceptable, so the clinic needs the previous radiotherapy plan with its doses and the imaging.
How AlenMed arranges CyberKnife treatment in Germany
AlenMed finds a radiosurgery department, translates and forwards the imaging and histology, requests the tumour board review and obtains a written estimate before the trip. It also arranges the visa invitation and an interpreter at the consultation and the planning CT.
Plan for how many days preparation and sessions take, when the follow-up scan is due, who monitors the patient at home, and in what form the documents arrive.
This material is for information only and is not an offer. The indication and the treatment plan are decided by a doctor in person.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
